Pembrolizumab-Induced Sarcoidosis-Like Immune-Related Adverse Events: A Pooled Analysis of Published Cases and Report of a Novel Manifestation Involving Phosphocalcic Metabolism.
Immune checkpoint inhibitors such as pembrolizumab can trigger immune-related adverse events, including rare sarcoidosis-like reactions (DISR), whose immunopathogenesis and clinical spectrum remain incompletely defined. We conducted a systematic review of all published cases of pembrolizumab-induced DISR, extracted and...